NYSEMKT: IGC
Igc Pharma Inc Stock Ownership - Who owns Igc Pharma?

Insider buying vs selling

Have Igc Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James P. MoranDirector2024-09-25588,235$0.34
$200.00kBuy

1 of 1

IGC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IGC insiders and whales buy or sell their stock.

IGC Shareholders

What type of owners hold Igc Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ram Mukunda5.87%5,328,430$2.18MInsider
Bradbury Strategic Investment Fund A Cayman Islands Registration No Cr3598575.51%5,000,000$2.05MInsider
James P. Moran2.26%2,048,137$839.74kInsider
Db Zwirn Co LP1.64%1,485,404$609.02kInsider
Richard K. Prins1.40%1,271,251$521.21kInsider
Claudia Grimaldi1.30%1,184,252$485.54kInsider
Ranga C. Krishna1.18%1,068,461$438.07kInsider
Steven Michael Oliveira0.85%772,196$316.60kInsider
Blackrock Inc0.78%703,798$288.56kInstitution
Geode Capital Management LLC0.77%703,303$288.35kInstitution

1 of 3

IGC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IGC3.35%22.33%Net Buying
BCAB27.10%35.36%Net SellingNet Selling
IMA75.90%24.10%Net BuyingNet Buying
KAPA1.05%32.68%Net Buying
XLO40.65%59.35%Net BuyingNet Buying

Igc Pharma Stock Ownership FAQ

Who owns Igc Pharma?

Igc Pharma (NYSEMKT: IGC) is owned by 3.35% institutional shareholders, 22.33% Igc Pharma insiders, and 74.33% retail investors. Ram Mukunda is the largest individual Igc Pharma shareholder, owning 5.33M shares representing 5.87% of the company. Ram Mukunda's Igc Pharma shares are currently valued at $2.18M.

If you're new to stock investing, here's how to buy Igc Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.